 |
Genetically engineered human recombinant IgG4 monoclonal antibody directed against human TNF alpha |
|---|---|
| Trade Name | |
| Orphan Indication | Crohn's disease |
| USA Market Approval | USA |
| USA Designation Date | 1997-12-11 00:00:00 |
| Sponsor | Celltech Chiroscience Limited;216 Bath Road, Berkshire; |
